Clinical Trial Update: Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of radiation-induced severe oral mucositis in cancers of the oral cavity, oropharynx, and hypopharynx has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Oropharynx Cancer, Hypopharynx Cancer | Phase 3 | Status: TERMINATED